Michael Schön, MD, is now a member of Scinai Immunotherapeutics Ltd’s Scientific Advisory Board.
Dr. Schön is a distinguished Professor and Director of the Department of Dermatology, Venereology, and Allergology at the University Medical Center Göttingen in Germany. He also serves as Vice Dean and Deputy Director for Research and Teaching and is the former director of the Lower Saxony Institute of Occupational Dermatology. From 2011 to 2024, he was the Editor-in-Chief of the Journal of the German Dermatological Society. Currently, he holds the position of Secretary General and Vice President of the European Dermatology Forum (EDF).
“It is a great pleasure and honor for me to be part of the advisory board for Scinai and to contribute to the success of their highly innovative pipeline,” he says in a news release. “In many areas of chronic inflammatory skin diseases, but also in other organ systems with immunologically mediated diseases, there is a significant unmet medical need. In my view, Scinai’s targeted immunological therapeutic approaches have excellent potential to provide exciting innovation in various areas of precision inflammation medicine.”
Amir Reichman, CEO of Scinai, adds: “We are thrilled to welcome Prof. Schön, a world-class expert in dermatology, particularly in psoriasis and atopic dermatitis, to our Scientific Advisory Board. Michael’s extensive experience as a dermatologist, having treated thousands of patients, and as a researcher with over 440 scientific publications in top-rated journals, along with his proven track record in drug development and clinical research, will be invaluable to Scinai. His insights will be crucial as we advance our pipeline of innovative I&I biological products. “
